Page last updated: 2024-10-30

metformin and Lymphopenia

metformin has been researched along with Lymphopenia in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Lymphopenia: Reduction in the number of lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Sullivan, TE1
Geary, CD1
Weizman, OE1
Geiger, TL1
Rapp, M1
Dorn, GW1
Overholtzer, M1
Sun, JC1

Other Studies

1 other study available for metformin and Lymphopenia

ArticleYear
Atg5 Is Essential for the Development and Survival of Innate Lymphocytes.
    Cell reports, 2016, 05-31, Volume: 15, Issue:9

    Topics: Animals; Autophagy; Autophagy-Related Protein 5; Cell Proliferation; Cell Survival; Homeostasis; Imm

2016